Peripheral Vascular Devices Market Size, Growth, Share & Trends Analysis

In 2025, drug-eluting stents dominated the angioplasty stents market. These stents demonstrate better clinical outcomes compared to bare-metal stents, as they significantly reduce neointimal hyperplasia and improve long-term vessel patency. As a result, doctors are increasingly willing to use them. Additionally, the market benefits from ongoing research and developments in polymer coatings and drug delivery systems. There is also a gradual shift towards utilizing endovascular therapies for complex peripheral lesions, along with physicians' growing preference for durable and minimally invasive solutions.

In 2025, abdominal aortic aneurysm stent grafts dominated the endovascular aneurysm repair stent grafts market. This market is positively impacted by the increasing number of patients with aneurysms, particularly among the elderly and individuals with high blood pressure, a history of smoking, or heart disease. Additionally, there is a strong clinical preference for performing endovascular aneurysm repair rather than open surgery due to the lower perioperative risks, shorter hospital stays, and faster recovery times associated with EVAR. Market growth is also supported by the improved production of low-profile, modular, and advanced stent graft designs that can accommodate complex anatomical conditions. Furthermore, advancements in imaging techniques and the growing number of specialized vascular centers offering these treatments are contributing to the expansion of this market segment.

In 2025, retrievable filters dominated the inferior vena cava filters market. The rise in the adoption of these filters in the peripheral vascular devices market is primarily due to the increasing incidence of venous thromboembolism (VTE) and the growing population of patients who cannot undergo anticoagulant therapy for extended periods. There is a progressive clinical trend towards using temporary measures against pulmonary embolism, especially in cases involving trauma, surgery, and high-risk patients, which is accelerating the usage of these filters. Additionally, market growth is attributed to the introduction of new filter designs that offer easier retrieval, fewer long-term complications, and improved safety during procedures. There is also a growing knowledge among doctors and enhanced methods for patient follow-up contributing to this trend.

In 2025, angiography catheters are leading the catheters market. Their success in the peripheral vascular devices sector is driven by the increasing prevalence of peripheral artery disease and other vascular disorders that require precise imaging for intervention. Many patients are opting for minimally invasive endovascular procedures. Additionally, angiography is being utilized for procedure planning and follow-up care. Continuous improvements in catheter design—such as enhanced trackability, better torque response, and improved radiopacity—are also contributing to their growing clinical adoption. Furthermore, the expansion of catheterization laboratories, a rising elderly population, and improved access to interventional vascular care, especially in developing countries, are all supporting market growth.

In 2025, old/normal balloons dominated the angioplasty balloons market. The success of these conventional balloons in the peripheral vascular devices market is primarily due to their lower costs, ease of use, and high clinical acceptance for lesion preparation, as well as pre- and post-dilatation in peripheral interventions. These balloons maintain their primary position in many applications and are often preferred in situations where high volumes and cost are significant concerns, particularly in hospitals with limited reimbursement for advanced technologies. Their excellent compatibility with various guidewires and stent systems, along with a consistent demand from emerging economies and routine peripheral angioplasty cases, continues to drive market growth.

In 2025, atherectomy devices dominated the plaque modification devices market. This market is experiencing growth due to the increasing incidence of peripheral artery disease (PAD) and the presence of complicated, calcified lesions that are difficult to manage with conventional angioplasty or stenting alone. These devices benefit patients throughout the entire procedure by enabling precise control over plaque removal, opening the vessel, and ensuring proper stent placement. The advancement of various atherectomy technologies—including directional, rotational, orbital, and laser systems—coupled with a rising preference for minimally invasive peripheral interventions and a growing inclination among physicians for vessel-preserving strategies, is further driving market growth in this sector.

In 2025, embolic protection devices dominated the hemodynamic flow alteration devices market. Their increasing popularity in the peripheral vascular devices segment is largely attributed to the rising incidence of peripheral artery disease and the gradual shift towards endovascular treatments, which carry a risk of distal embolization. Enhanced awareness among doctors regarding complications associated with these interventions, such as embolic strokes and tissue death, is driving the demand for devices that can enhance patient safety. Additionally, technological innovations that improve the deliverability, capture efficiency, and compatibility of these devices with blood vessels, along with their growing use in complex peripheral interventions and minimally invasive procedures, are further contributing to market growth.

In 2025, guidewires held a prominent position in the peripheral vascular devices market. The growth of guidewires in this sector is driven by the increasing number of minimally invasive endovascular procedures for treating peripheral artery disease and other vascular disorders. Guidewires are essential at all stages of these interventions, as they assist with lesion crossing, device delivery, and procedural precision, continuously sustaining demand. Additionally, technological advancements—such as enhanced torque control, improved coatings for better trackability, and specialized designs for addressing complex and calcified lesions—are contributing to market growth. The expansion of catheterization lab infrastructures and the rising global adoption of peripheral interventions further accelerate this trend.

In 2025, hospitals led the peripheral vascular devices market in terms of end users. The hospitals sector is the primary driver of the growing demand for these devices, as they are equipped to handle a high volume of complex peripheral vascular cases. These cases require modern infrastructure, multidisciplinary expertise, and comprehensive post-surgical care. Hospitals are increasingly adopting hybrid operating rooms, advanced imaging systems, and specialized vascular teams, enabling them to effectively treat severe cases of peripheral artery disease, chronic total occlusions, and high-risk patients. Additionally, favorable reimbursement rates for inpatient procedures, a rising number of emergency admissions due to vascular complications, and hospitals' roles as major centers for clinical trials and the adoption of new technologies all contribute to their strong position as the primary end users of peripheral vascular devices.